Added Therapeutic Value of Memantine in the Treatment of Moderate to Severe Alzheimer's Disease

Author： Heinen-Kammerer T.   Rulhoff H.   Nelles S.   Rychlik R.  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.26, Iss.6, 2006-01, pp. : 303-314

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is memantine a breakthrough in the treatment of moderate-to-severe Alzheimer’s disease?

By Doggrell Sheila  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 10, 2003-10 ,pp. : 1857-1860

Informa Healthcare

Access to resources Recommend Favorite

Spotlight on Memantine in Moderate to Severe Alzheimer's Disease†

By McKeage Kate  

Drugs & Aging, Vol. 27, Iss. 2, 2010-02 ,pp. : 177-179

Adis International

Access to resources Recommend Favorite

Memantine: A Pharmacoeconomic Review of its Use in Moderate-to-Severe Alzheimer's Disease

By Plosker Greg L.   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 23, Iss. 2, 2005-01 ,pp. : 193-206

Adis International

Access to resources Recommend Favorite

Memantine: A Review of its Use in Moderate to Severe Alzheimer's Disease

By McKeage Kate  

CNS Drugs, Vol. 23, Iss. 10, 2009-10 ,pp. : 881-897

Adis International

Access to resources Recommend Favorite

Resource Utilisation and Cost Analysis of Memantine in Patients with Moderate to Severe Alzheimer's Disease

By Wimo A.  

PharmacoEconomics, Vol. 21, Iss. 5, 2003-01 ,pp. : 327-340

Adis International

Access to resources Recommend Favorite